Amid news of the splashy $4.8…
Amid news of the splashy $4.8 billion Amicus buy, BioMarin [...]
Two years after Gilead secured the…
Two years after Gilead secured the first option on Assembly [...]
Boehringer Ingelheim has opened…
Boehringer Ingelheim has opened another front in its attack on [...]
Samsung Bio’s U.S. subsidiary…
Samsung Bio’s U.S. subsidiary will pay $280 million to acquire [...]
Big Pharma-backed Aktis Oncology…
Big Pharma-backed Aktis Oncology has announced plans to go public [...]
Having kicked off the year with a…
Having kicked off the year with a $200 million series [...]
Ipsen may be a recent entrant into…
Ipsen may be a recent entrant into the antibody-drug conjugate [...]
¿Por cuánto tiempo puedes tomar antidepresivos?
Estos medicamentos, creados para hacerte sentir bien, son difíciles de [...]
Trump Announces Pricing Deals With Nine Drugmakers
The companies were the latest to agree to sell drugs [...]
F.D.A. Turmoil Keeps Spotlight on Its Commissioner
The agency’s high-level turnover and conflicting policy decisions on drug [...]